Retrospective data generally refers to data that has already been collected for another purpose and is being used retrospectively to answer a new research question. This data can come from various sources, such as electronic health records, claims databases, or patient registries, and is often used to generate RWE.
On the other hand, secondary use of existing data refers to the practice of using existing data for a purpose other than the one for which it was originally collected. This can include using data from clinical trials for post-market surveillance or using data from a patient registry for comparative effectiveness research.
While retrospective data can be one type of existing data that is used for secondary purposes, not all secondary uses of data involve retrospective data. For example, prospective data collected for one purpose, such as routine clinical care, can be used for secondary purposes, such as generating RWE.
In summary, retrospective data and secondary use of existing data are related but not interchangeable terms in the context of RWE. Retrospective data is a type of existing data that can be used for secondary purposes, but not all secondary uses of data involve retrospective data.
Share this story...
Real World Evidence (RWE) 101 – SOPs and Regional Regulations
RWE 101 - SOPs and Regional Regulations In the realm of quality assurance (QA), it's vital that standard operating procedures (SOPs) are crafted in a way that accurately and [...]
Real World Evidence (RWE) 101 – Standard Operating Procedures
RWE 101 - Standard Operating Procedures Standard Operating Procedures (SOPs) are critical for the operation of any business, particularly in regulated industries like pharmaceuticals where precision, safety, and compliance [...]
Real World Evidence (RWE) 101 – Publications
RWE 101 - Publications The term RWE stands for Real-World Evidence, which is evidence derived from real-world data (RWD). RWD are data relating to patient health status and/or the [...]
Real World Evidence (RWE) 101 – Archiving Specifics
RWE 101 - Archiving Specifics Proper archiving of clinical study documents is an important practice for maintaining the quality, integrity, and usability of study data, and for ensuring regulatory [...]
Real World Evidence (RWE) 101 – Archiving Generics
RWE 101 - Archiving Generics In the context of health research, both observational studies and clinical trials are crucial for understanding disease processes, patient outcomes, and the safety and [...]
Real World Evidence (RWE) 101 – Study Close-out
RWE 101 - Study Close-Out Closing out an observational study involves several key steps to ensure that all study activities are concluded properly, and data integrity is maintained. Here [...]







